Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.

Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K.

Indian J Ophthalmol. 2007 Jan-Feb;55(1):75-6.

2.

Antivascular endothelial growth factor for retinopathy of prematurity.

Mintz-Hittner HA, Best LM.

Curr Opin Pediatr. 2009 Apr;21(2):182-7. doi: 10.1097/MOP.0b013e32832925f9. Review.

PMID:
19300261
4.

Anterior segment uses of bevacizumab.

Bahar I, Yeung SN, Sella R, Slomovic A.

Curr Opin Ophthalmol. 2012 Jul;23(4):303-16. doi: 10.1097/ICU.0b013e3283548459. Review.

PMID:
22634640
5.

Bevacizumab (avastin) for the treatment of retinopathy of prematurity.

Beaulieu MJ.

Neonatal Netw. 2012 Jul-Aug;31(4):242-7. Review. No abstract available.

PMID:
22763251
6.

Management of retinopathy of prematurity.

Fleck BW.

Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F454-6. doi: 10.1136/archdischild-2013-303933. Epub 2013 Jun 27. Review.

PMID:
23813885
7.

Are we there yet? Bevacizumab therapy for retinopathy of prematurity.

Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE.

Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F170-4. doi: 10.1136/archdischild-2011-301148. Epub 2011 Dec 30. Review.

PMID:
22209748
8.

Anti-VEGF therapy with bevacizumab for anterior segment eye disease.

Hosseini H, Nowroozzadeh MH, Salouti R, Nejabat M.

Cornea. 2012 Mar;31(3):322-34. doi: 10.1097/ICO.0b013e31822480f9. Review.

PMID:
22157572
9.

Bevacizumab (Avastin).

Mukherji SK.

AJNR Am J Neuroradiol. 2010 Feb;31(2):235-6. doi: 10.3174/ajnr.A1987. Epub 2009 Dec 24. Review.

10.

Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition.

Lin KL, Hirose T, Kroll AJ, Lou PL, Ryan EA.

Semin Ophthalmol. 2009 Mar-Apr;24(2):70-6. doi: 10.1080/08820530902800108. Review.

PMID:
19373689
11.

[New therapeutic approaches in the treatment of retinopathy of prematurity].

Jandeck C.

Klin Monbl Augenheilkd. 2009 Nov;226(11):914-20. doi: 10.1055/s-0028-1109650. Epub 2009 Oct 1. Review. German.

PMID:
19798624
12.

A platform of integrative studies from in vitro to in vivo experiments: towards drug development for ischemic retinopathy.

Jo DH, Kim JH, Kim JH.

Biomed Pharmacother. 2015 Feb;69:367-73. doi: 10.1016/j.biopha.2014.12.027. Epub 2014 Dec 24. Review.

PMID:
25661384

Supplemental Content

Support Center